DOI: 10.1055/s-00023610

Drug Research

References

Udell JA, Bhatt DL, Braunwald E. et al.
Investigators Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial.

Diabetes Care 2015;
38: 696-705

Download Bibliographical Data

Access: